medical device investing Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT FDA Clinical Trial
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer